PLSMPulsenmore Ltd

For fans of Austin Powers, the phrase "One million dollars!" became one of cinema's most memorable jokes, but Pulsenmore’s (NASDAQ:PLSM) newly announced $1 million government-backed artificial intelligence initiative could represent something far more meaningful than a punchline. The company has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program, led by the Israel Innovation Authority and the Ministry of Health, to develop and clinically validate AI applications for its connected home ultrasound platform.

Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-market session. The company's market cap stands at $25.1 million. Q32 Bio (NASDAQ:QTTB) stock rose 65.92% to $18.6. Theread more...

Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project PR Newswire RAMAT GAN, Israel, July 13...

Pulsenmore (NASDAQ: PLSM) stock dips premarket after announcing a $7.5M private placement to fund its U.S. commercial expansion.read more...

Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor PR Newswire RAMAT GAN, Israel, June 25, 2026 RAMAT GAN...

Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's regular session. The market value of their outstanding shares is at $22.1 million. Icecure Medical (NASDAQ:ICCM) stockread more...

Pulsenmore’s home ultrasound platform will be used by Ouma Health, the largest maternity telemedicine company in the U.S.

Investors looking for companies that are delivering tangible catalysts, rather than distant promises, will like today’s list, which spans from brain cancer therapies advancing internationally to AI-designed biologics, home healthcare technologies, one of the largest humanoid robotics transactions of the year, and a good old burger play. Several of these stories are entering catalyst-rich periods that could define the second half of 2026. $WEN, $NTHI, $ABSI, $PLSM, $FRTT, $RUN, $TSLA, $CCXI

PLSM stock surges over 200% premarket as Pulsenmore partners with Ouma Health to bring FDA-authorized home ultrasound to the U.S.read more...